|
|
Article: Cancer Vaccine Research Is Coming To Fruition, With A Number Of Products Now In Phase III Trials And 15 Therapeutic Cancer Vaccines Realistically Expected To Launch By 2013.
- Article from:
- Business Wire
- Article date:
- June 11, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/eb249c/cancer_vaccine_dev) has announced the addition of the "Cancer Vaccine Developments to 2013 + Cancer Vaccine Tracker" report to their offering.
The launch of Sanofi Pasteur MSD's Gardasil and GSK's Cervarix has propelled cancer vaccines from research obscurity to a key area of commercial and clinical interest. But can the sector capitalise on these gains and really fulfil its promise?
By 2010, the global cancer market is expected to generate sales in excess of US$60 billion due to growth in the sales of existing innovative products and the launch of nearly 60 new ...